Related Experiment Videos
[Intrauterine growth restriction].
Elzbieta Lipecka-Kidawska1, Leszek Gottwald, Katarzyna Niewiadomska-Jarosik
1Klinika Patologii Ciazy. igp@psk2.am.lodz.pl
Przeglad Lekarski
|February 9, 2006
Summary
Intrauterine growth restriction (IUGR) affects 1-10% of pregnancies, leading to poorer outcomes. This review covers IUGR causes, diagnosis, monitoring, and neonatal impacts.
Area of Science:
- Obstetrics and Gynecology
- Neonatology
- Fetal Medicine
Context:
- Intrauterine growth restriction (IUGR) impacts 1-10% of pregnancies globally.
- Prevalence doubles in high-risk pregnancies.
- Associated with adverse obstetric and long-term neonatal outcomes.
Purpose:
- To review the etiology, diagnostics, and monitoring of IUGR.
- To outline the consequences of IUGR for neonates.
- To discuss the impact on the neonatal period.
Summary:
- IUGR etiology is multifactorial, involving placental insufficiency, genetic factors, and maternal conditions.
- Diagnostic methods include ultrasound biometry, Doppler velocimetry, and biochemical markers.
- Monitoring focuses on fetal well-being and timely intervention.
Impact:
- Improved understanding of IUGR management.
- Enhanced neonatal care for affected infants.
- Reduced long-term complications associated with fetal growth restriction.